BioLineRx
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $195 | $427 | $304 | $255 |
Gross Profit | 91 | 343 | 232 | 221 |
EBITDA | -3,343 | -554 | -3,488 | 5,712 |
EBIT | -3,407 | -673 | -3,664 | 5,547 |
Net Income | -1,393 | -977 | -3,940 | 5,127 |
Net Change In Cash | 195 | 427 | 304 | 255 |
Free Cash Flow | -3,254 | -2,106 | -177 | -2,591 |
Cash | 3,249 | 7,914 | 7,189 | 9,036 |
Basic Shares | 4,351 | 3,949 | 3,949 | 79,856 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $1,189 | $28,940 | $4,800 | $0 |
Gross Profit | 430 | 19,677 | 1,108 | -654 |
EBITDA | -9,841 | 3,918 | -57,086 | -28,503 |
EBIT | -10,368 | -147 | -58,470 | -29,157 |
Net Income | -1,184 | -9,221 | -60,614 | -24,951 |
Net Change In Cash | 1,189 | 28,940 | 4,800 | 0 |
Free Cash Flow | -8,163 | -43,927 | -22,905 | -26,556 |
Cash | 3,249 | 10,436 | 4,255 | 10,587 |
Basic Shares | 4,108 | 79,873 | 64,224 | 51,597 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.32 |
2025-09-30 | -$0.22 |
2025-06-30 | -$1.01 |
2025-03-31 | -$1.50 |
